成纤维细胞CD148缺陷促进肺纤维化发生
研究探讨CD148在特发性肺纤维化(IPF)成纤维细胞促纤维化表型中的作用。条件性成纤维细胞CD148敲除小鼠在博来霉素处理后肺纤维化加重,而CD148过表达可逆转IPF成纤维细胞的促纤维化表型。CD148激活肽SDC2-pep在体内减轻肺纤维化并抑制IPF成纤维细胞活化,提示靶向CD148可能成为IPF治疗策略。
要点
- IPF肺及成纤维细胞中CD148表达下调,沉默CD148促进细胞外基质产生并增加凋亡抵抗。
- 成纤维细胞CD148敲除小鼠博来霉素诱导的肺纤维化较对照加重。
- SDC2-pep在体内减轻肺纤维化并抑制IPF来源成纤维细胞活化。
核心结论
- 肺成纤维细胞CD148激活通过减少p62积累、抑制NF-κB介导的促纤维化基因表达发挥抗纤维化作用。
- 靶向CD148磷酸酶(如SDC2-pep激活配体)可能是IPF的潜在治疗策略。
研究设计与样本
- 研究采用条件性成纤维细胞特异性CD148敲除小鼠,暴露于博来霉素后评估肺纤维化。
- 分离小鼠肺成纤维细胞、人IPF肺成纤维细胞及人IPF患者精切肺切片进行实验处理。
- 评估来源于syndecan-2的CD148激活18氨基酸模拟肽(SDC2-pep)的治疗潜力。
主要发现
- IPF肺和成纤维细胞中CD148表达下调。
- 人IPF肺成纤维细胞中沉默CD148增加细胞外基质产生和凋亡抵抗,过表达CD148逆转促纤维化表型。
- CD148成纤维细胞特异性敲除小鼠博来霉素攻击后肺纤维化较对照增加。
- CD148缺陷成纤维细胞显示PI3K/Akt/mTOR信号过度激活、自噬减少、p62积累增加,诱导NF-κB激活和促纤维化基因表达。
- SDC2-pep在体内减少肺纤维化并抑制IPF来源成纤维细胞活化;在IPF和对照患者精切肺切片中,SDC2-pep减弱IPF及促纤维化刺激的正常肺的促纤维化基因表达。
临床怎么用
- CD148表达下调与IPF成纤维细胞促纤维化表型相关,可作为潜在生物标志物或治疗靶点探索。
- SDC2-pep等CD148激活配体在临床前模型中显示抗纤维化效果,支持进一步转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: CD148/PTRJ (receptor-like protein tyrosine phosphatase η) exerts antifibrotic effects in experimental pulmonary fibrosis via interactions with its ligand syndecan-2; however, the role of CD148 in human pulmonary fibrosis remains incompletely characterized.Objectives: We investigated the role of CD148 in the profibrotic phenotype of fibroblasts in idiopathic pulmonary fibrosis (IPF).Methods: Conditional CD148 fibroblast-specific knockout mice were generated and exposed to bleomycin and then assessed for pulmonary fibrosis. Lung fibroblasts (mouse lung and human IPF lung), and precision-cut lung slices from human patients with IPF were isolated and subjected to experimental treatments. A CD148-activating 18-aa mimetic peptide (SDC2-pep) derived from syndecan-2 was evaluated for its therapeutic potential.Measurements and Main Results: CD148 expression was downregulated in IPF lungs and fibroblasts. In human IPF lung fibroblasts, silencing of CD148 increased extracellular matrix production and resistance to apoptosis, whereas overexpression of CD148 reversed the profibrotic phenotype. CD148 fibroblast-specific knockout mice displayed increased pulmonary fibrosis after bleomycin challenge compared with control mice. CD148-deficient fibroblasts exhibited hyperactivated PI3K/Akt/mTOR signaling, reduced autophagy, and increased p62 accumulation, which induced NF-κB activation and profibrotic gene expression. SDC2-pep reduced pulmonary fibrosis in vivo and inhibited IPF-derived fibroblast activation. In precision-cut lung slices from patients with IPF and control patients, SDC2-pep attenuated profibrotic gene expression in IPF and normal lungs stimulated with profibrotic stimuli.Conclusions: Lung fibroblast CD148 activation reduces p62 accumulation, which exerts antifibrotic effects by inhibiting NF-κB-mediated profibrotic gene expression. Targeting the CD148 phosphatase with activating ligands such as SDC2-pep may represent a potential therapeutic strategy in IPF.
引用
- Tsoyi K, Liang X, De Rossi G, et al. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021. PMID: 33784491. doi:10.1164/rccm.202008-3100OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。